Patron Partners’s United Therapeutics UTHR Stock Holding History

Patron Partners’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$210K	Hold	388	–	–	0.08%	188
2026 Q1	$230K	Buy	+388	New	+$193K	0.1%	172

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Patron Partners's UTHR Position: Q2 2026 in Review

Patron Partners held its United Therapeutics (UTHR) position steady in Q2 2026 at 388 shares worth $210K. The position accounts for 0.08% of the portfolio, ranked #188.

Patron Partners first reported a position in UTHR in Q1 2026 and has held it in 2 quarters since. The position peaked at $230K in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Patron Partners held 388 shares of United Therapeutics worth $210K as of Q2 2026.
Patron Partners left its United Therapeutics share count unchanged in Q2 2026.
United Therapeutics made up 0.08% of Patron Partners's portfolio in Q2 2026, its #188 holding.
Patron Partners first reported a position in United Therapeutics in Q1 2026 and has held it in 2 quarters since.
Patron Partners's United Therapeutics position peaked at $230K in Q1 2026.
880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Patron Partners's 13F filing for Q2 2026, filed 11 Aug 2026.